<DOC>
	<DOCNO>NCT00037518</DOCNO>
	<brief_summary>This study assess investigational medication patient severe primary hyperparathyroidism parathyroid cancer .</brief_summary>
	<brief_title>A Study Investigational Medication Severe Primary Hyperparathyroidism Parathyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Parathyroid Neoplasms</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Patients must parathyroid carcinoma severe primary hyperparathyroidism ; * Abnormally elevated calcium level 12.5 mg/dL ; * Not pregnant nursing ; * Not type cancer parathyroid carcinoma within last 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Severe primary hyperparathyroidism</keyword>
	<keyword>Parathyroid carcinoma</keyword>
</DOC>